Erfindergemeinschaft UroPep GbR v. Eli Lilly and Company et al, No. 2:15-cv-01202 (E.D. Tex. July 18, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

P laintiff Erfindergemeinschaft UroPep GbR (“UroPep”) has moved for entry of a bill of costs in this case. Dkt. No. 377. Defendant Eli Lilly and Company opposes in part. Dkt. No. 384. The motion is GRANTED IN PART and DENIED IN PART. The parties have agreed on the bulk of the issues pertaining to costs, and they have settled on an award in the amount of $100,485.08 for the unopposed costs in this case.